Leitão Cristiane B, Canani Luís H, Kramer Caroline K, Boza Juliana C, Pinotti Antônio F, Gross Jorge L
Endocrine Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Diabetes Care. 2007 May;30(5):1255-60. doi: 10.2337/dc06-2131. Epub 2007 Feb 15.
To evaluate the impact of masked hypertension in normotensive type 2 diabetic patients on microvascular complications and echocardiographic parameters.
A cross-sectional study was conducted in 135 normotensive patients with type 2 diabetes. Patients underwent urinary albumin excretion rate (UAER) measurement, echocardiography, and 24-h ambulatory blood pressure monitoring (ABPM). Patients with increased daytime blood pressure levels (> or = 135/85 mmHg) were classified as having masked hypertension.
The prevalence of masked hypertension was 30% (n = 41). Normotensive and masked hypertensive subjects, based on ambulatory blood pressure, were not different in terms of age, diabetes duration, smoking status, BMI, waist circumference, serum creatinine, glycemic, or lipid profiles. The office systolic blood pressure was higher in those with masked hypertension (127.8 +/- 7.5 vs. 122.9 +/- 10.2 mmHg, P = 0.003) than in the normotensive group. UAER also was increased in the group with masked hypertension (21.3 microg/min [range 2.5-1,223.5] vs. 8.1 microg/min [1.0-1,143.0], P = 0.001), as was the interventricular septum (1.01 +/- 0.15 vs. 0.94 +/- 0.13 cm, P = 0.015) and posterior wall (0.96 +/- 0.12 vs. 0.90 +/- 0.10 cm, P = 0.006) thickness. After adjustments for diabetes duration, sex, smoking, LDL cholesterol, and A1C values, all associations were sustained for daytime systolic blood pressure but not for office systolic blood pressure.
Type 2 diabetic patients with masked hypertension have higher UAER as well as enlargement of ventricular walls compared with the normotensive patients, according to ABPM. Therefore, ABPM is important to identify this high-risk group so as to be able to take interventionist measures.
评估血压正常的2型糖尿病患者中隐匿性高血压对微血管并发症和超声心动图参数的影响。
对135例血压正常的2型糖尿病患者进行了一项横断面研究。患者接受了尿白蛋白排泄率(UAER)测量、超声心动图检查和24小时动态血压监测(ABPM)。白天血压水平升高(≥135/85 mmHg)的患者被归类为隐匿性高血压。
隐匿性高血压的患病率为30%(n = 41)。根据动态血压,血压正常和隐匿性高血压患者在年龄、糖尿病病程、吸烟状况、BMI、腰围、血清肌酐、血糖或血脂谱方面无差异。隐匿性高血压患者的诊室收缩压高于血压正常组(127.8±7.5 vs. 122.9±10.2 mmHg,P = 0.003)。隐匿性高血压组的UAER也升高(21.3微克/分钟[范围2.5 - 1223.5] vs. 8.1微克/分钟[1.0 - 1143.0],P = 0.001),室间隔厚度(1.01±0.15 vs. 0.94±0.13 cm,P = 0.015)和后壁厚度(0.96±0.12 vs. 0.90±0.10 cm,P = 0.006)也是如此。在对糖尿病病程、性别、吸烟、低密度脂蛋白胆固醇和糖化血红蛋白值进行调整后,所有关联在白天收缩压方面仍然存在,但在诊室收缩压方面不存在。
根据动态血压监测,隐匿性高血压的2型糖尿病患者与血压正常的患者相比,UAER更高,心室壁也更厚。因此,动态血压监测对于识别这一高危人群很重要,以便能够采取干预措施。